Researchers of the Indian Institute of Science (IISc) in Bengaluru, along with other collaborators, identified potential blood-based biomarkers for predicting disease progression and survival times among people with late-stage brain tumours.

Highlights

• As per release, team behind this innovation include researchers from:

1. Centre for Bio Systems Science and Engineering (BSSE), IISc
2. Mazumdar Shaw Centre for Translational Research and
3. Mazumdar Shaw Medical Foundation.

• The researchers analysed tumour and blood samples from individuals with gliomas in order to identify surface proteins on immune cells in blood.
• The study was published in OncoImmunology.

Late-stage gliomas

As per researchers, late-stage gliomas like grade three and grade four gliomas are linked with a poor prognosis. Such tumour is hard to treat and patient is likely to have low chance of survival.